Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mallinckrodt Vision For Growth Emphasizes Acthar, Ofirmev

Oct 20 2014

• By Jessica Merrill

Related Content

Questcor Expansion Strategy Pays Off For Acthar

Aug 14 2013

Cadence Builds Case For Branded IV Acetaminophen; Can It Reduce Opioid Use?

Nov 08 2010

Related Companies

Mallinckrodt plc

Cadence Pharmaceuticals, Inc.

Covidien plc

Cubist Pharmaceuticals, Inc.

The Medicines Company

Additional Topics

Strategy Business Strategies Deals BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window